{
    "title": "Intercept's NASH drug fails late-stage trial, shares tumble",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11266785/Intercept-Pharmas-liver-disease-drug-fails-late-stage-trial.html",
    "date": "2022-09-30",
    "keywords": [
        "drug",
        "liver",
        "fibrosis",
        "intercept",
        "study",
        "khushi",
        "mandowara",
        "treatment",
        "steatohepatitis",
        "nash",
        "approval",
        "acid",
        "inc",
        "friday",
        "goal",
        "latestage",
        "disease",
        "transplant",
        "stage",
        "buildup",
        "scar",
        "tissue",
        "cirrhosis",
        "cancer",
        "failure",
        "plan",
        "track",
        "end",
        "year",
        "food",
        "administration",
        "uncertainty",
        "risk",
        "july",
        "placebo",
        "efficacy",
        "view",
        "effect",
        "analyst",
        "yee",
        "worsening",
        "morning",
        "trading",
        "reporting",
        "bengaluru",
        "editing",
        "arun",
        "koyyur"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}